微生物组和刺激性肠综合征:治疗的新希望
1Sara Gleasman-DeSimone, PhD, RN, NP-C, Le Moyne College Nursing Department, Syracuse, New York.
概括
刺激性肠综合征 (IBS) 影响了数百万人的生活质量. 研究探讨了肠道微生物群.
科学领域:
- 胃肠病学 胃肠病学
- 微生物组研究 微生物组研究
- 临床医学 临床医学
背景情况:
- 刺激性肠综合征 (IBS) 是一种普遍的胃肠道疾病,影响15%-20%的美国人口.
- IBS症状显著降低患者的生活质量,并导致高医疗费用.
- 肠道微生物组在IBS中的作用是一个新兴和关键的研究领域.
研究的目的:
- 审查目前对IBS的理解,以及肠道微生物群对其症状的影响.
- 探索开发个性化IBS治疗的新型研究途径.
- 为医疗保健提供者提供知识,以改善患者管理和生活质量.
主要方法:
- 关于IBS和肠道微生物组研究的文献综述.
- 在IBS中对微生物组-肠轴的新兴科学发现进行分析.
- 综合用于临床应用的信息.
主要成果:
- 肠道微生物群在IBS的病理生理学中起着重要作用.
- 特定的微生物变化与独特的IBS症状概况有关.
- 新兴研究强调了微生物组内的潜在治疗点.
结论:
- 了解微生物组为个性化IBS治疗提供了新的途径.
- 准肠道微生物群可以缓解症状,改善IBS患者的生活质量.
- 需要进一步的研究来将微生物组发现转化为有效的临床干预措施.
相关概念视频
Irritable Bowel Syndrome I: Introduction
268
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
268
Irritable Bowel Syndrome III: Medical and Nursing Management
195
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
195
Drugs for Treatment of Diarrhea-Predominant IBS
159
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
159
Drugs for Treatment of Constipation-Predominant IBS
157
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
157
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
156
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
156


